VYNE Therapeutics Inc (VYNE)
2.25
-0.05
(-2.17%)
USD |
NASDAQ |
Apr 19, 11:37
VYNE Therapeutics Profit Margin (Quarterly): -8.14K% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -8.14K% |
| September 30, 2023 | -5.78K% |
| June 30, 2023 | -7.45K% |
| March 31, 2023 | -5.68K% |
| December 31, 2022 | -165.8K% |
| September 30, 2022 | -5.66K% |
| June 30, 2022 | -6.73K% |
| March 31, 2022 | |
| December 31, 2021 | -4.24K% |
| September 30, 2021 | -16.00K% |
| June 30, 2021 | -6.75K% |
| March 31, 2021 | -8.93K% |
| December 31, 2020 | -540.9% |
| September 30, 2020 | -756.0% |
| June 30, 2020 | -1.43K% |
| Date | Value |
|---|---|
| March 31, 2020 | -2.30K% |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | -82.29% |
| March 31, 2018 | -2.55K% |
| December 31, 2017 | -334.3% |
| September 30, 2017 | -899.0% |
| June 30, 2017 | -1.37K% |
| March 31, 2017 | -1.22K% |
| December 31, 2016 | -1.07K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-165.8K%
Minimum
Dec 2022
-540.9%
Maximum
Dec 2020
-16.41K%
Average
-5.78K%
Median
Sep 2023
Profit Margin (Quarterly) Benchmarks
| Viking Therapeutics Inc | -- |
| AN2 Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | -110.2% |
| Palatin Technologies Inc | -385.6% |
| iBio Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -81.22% |
| Return on Assets | -65.28% |
| Return on Invested Capital | -81.22% |
| Operating Margin (Quarterly) | -8.99K% |